Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schlemmer

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Medical Research|July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trialMarcus Schlemmer, S Bauer, R Schütte, et al.
British Journal of Haematology|December 21, 2004
Impact of human herpesvirus-6 after haematopoietic stem cell transplantationMarcus Hentrich, Daniel Oruzio, Gundula Jäger, et al.
European Journal of Radiology|September 2, 2009
Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapyMarcus Schlemmer, Steven P Sourbron, Nicole Schinwald, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 24, 2015
Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?Marcus Schlemmer, Ulrich Suchner, Barbara Schäpers, et al.
BMC Palliative Care|April 7, 2018
Redefining diagnosis-related groups (DRGs) for palliative care - a cross-sectional study in two German centresMatthias Vogl, Eva Schildmann, Reiner Leidl, et al.
Oncology|March 9, 2007
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomasMarcus Schlemmer, Clemens-Martin Wendtner, Martin Falk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2005
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mgJohn R Zalcberg, Jaap Verweij, Paolo G Casali, et al.
The American Journal of Surgical Pathology|August 30, 2008
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822YAndreas Thalheimer, Marcus Schlemmer, Marco Bueter, et al.
Onkologie|March 4, 2006
Immunotherapy of lung cancer: an updateDominik Rüttinger, Hauke Winter, Natasja K van den Engel, et al.
Journal of Translational Medicine|September 18, 2007
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune responseDominik Rüttinger, Natasja K van den Engel, Hauke Winter, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Medical Research|July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trialMarcus Schlemmer, S Bauer, R Schütte, et al.
British Journal of Haematology|December 21, 2004
Impact of human herpesvirus-6 after haematopoietic stem cell transplantationMarcus Hentrich, Daniel Oruzio, Gundula Jäger, et al.
European Journal of Radiology|September 2, 2009
Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapyMarcus Schlemmer, Steven P Sourbron, Nicole Schinwald, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 24, 2015
Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?Marcus Schlemmer, Ulrich Suchner, Barbara Schäpers, et al.
BMC Palliative Care|April 7, 2018
Redefining diagnosis-related groups (DRGs) for palliative care - a cross-sectional study in two German centresMatthias Vogl, Eva Schildmann, Reiner Leidl, et al.
Oncology|March 9, 2007
Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomasMarcus Schlemmer, Clemens-Martin Wendtner, Martin Falk, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2005
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mgJohn R Zalcberg, Jaap Verweij, Paolo G Casali, et al.
The American Journal of Surgical Pathology|August 30, 2008
Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822YAndreas Thalheimer, Marcus Schlemmer, Marco Bueter, et al.
Onkologie|March 4, 2006
Immunotherapy of lung cancer: an updateDominik Rüttinger, Hauke Winter, Natasja K van den Engel, et al.
Journal of Translational Medicine|September 18, 2007
Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune responseDominik Rüttinger, Natasja K van den Engel, Hauke Winter, et al.
Pageof 3